PEN — Penumbra Inc · P/E 237, rev $764.8M

Penumbra Inc (PEN) is a medical devices company listed on US.

Latest reported PEN revenue for 2026-06-30 was $764.8M. Net income was $67.4M. PEN currently screens at market cap $9.93B and trailing P/E 237.4.

Use this PEN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PEN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PEN SEC filings page. Lician reads the product cache first so this HTML stays unique to Penumbra Inc even when a live quote feed is slow.

Penumbra Inc latest statements (FY2025)

Latest cached year on this hub. Full PEN income, balance, and cash tables.

  • Revenue$1.40B
  • Net Income$177.7M
  • Total Assets$1.83B
  • Total Debt$0
  • Free Cash Flow$174.9M

PEN recent filings